circRNA-5692 had been found to inhibit HCC development and EMT progression by accelerating demethylation of the DAB2IP gene and enhancing its expression and circRNA-5692 also acted as a tumor suppressor via the miR-328-5p/DAB2IP pathway (59). This evidence concerns the gene DAB2IP and hepatocellular carcinoma.